Delivery Order SPE2DB20D1050-SPE2DB25FH93X
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,323.73 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count) on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with the DLA. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a $1,633.20 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Febuxostat 80 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the vendor's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $1,394.19, with an ultimate completion date of August 15, 2025. The contract involves no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,258.08 on May 12, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion deadline of May 13, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,972.23 to AmerisourceBergen Drug Corp for Febuxostat 40 mg tablets (30-count packages) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a $1,419.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets in quantities of 30, with an ultimate completion date of September 3, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a $4,793.15 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is not set aside for any particular business category and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, with completion targeted for September 29, 2025. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,551.16 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units) on August 29, 2025, with completion scheduled for September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the companies' long-standing relationship supporting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,273.53 on July 28, 2025, for the supply of Febuxostat 80 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Febuxostat 80 mg tablets in quantities of 30, with a ceiling value of $1,033.58. This firm fixed-price delivery order, which is set to be completed by July 23, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH93XDelivery Order
The Defense Logistics Agency awarded a $7,885.53 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Febuxostat 40 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with a completion deadline of September 25, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capability in fulfilling federal medical procurement requirements through competitive award processes. The company serves critical military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard, through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This award reflects the company's ongoing role as a primary vendor within DLA's pharmaceutical supply chain supporting Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 9/24/25 |